Vident Advisory’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-110,567
| Closed | -$244K | – | 1668 |
|
|
2025
Q1 | $244K | Buy |
110,567
+82,182
| +290% | +$182K | ﹤0.01% | 1350 |
|
|
2024
Q4 | $155K | Sell |
28,385
-98
| -0.3% | -$534 | ﹤0.01% | 1379 |
|
|
2024
Q3 | $237K | Sell |
28,483
-8,425
| -23% | -$70K | 0.01% | 1222 |
|
|
2024
Q2 | $264K | Buy |
36,908
+12,169
| +49% | +$87.1K | 0.01% | 1173 |
|
|
2024
Q1 | $214K | Buy |
24,739
+9,497
| +62% | +$82.3K | ﹤0.01% | 1182 |
|
|
2023
Q4 | $99.8K | Sell |
15,242
-18,943
| -55% | -$124K | ﹤0.01% | 1281 |
|
|
2023
Q3 | $342K | Buy |
+34,185
| New | +$342K | 0.01% | 843 |
|